Final answer:
Methyl naltrexone seems to be a typographical error in relation to naltrexone, an opioid antagonist used to help individuals in narcotic treatment programs remain drug-free. Naltrexone has been clinically available since 1985, is effective orally, and requires chronic therapy. It significantly aids those with a high motivation to overcome narcotic dependence.
Step-by-step explanation:
Methyl naltrexone, which is not mentioned in the provided references, might be confused with naltrexone. Naltrexone itself is a medication that has been clinically available since 1985 and serves as an opioid antagonist. This medication is similar in action to naloxone but differs in its effectiveness when taken orally and its longer duration. With a dosage of 50 to 100 mg, it is suitable for chronic therapy in narcotic treatment programs. In individuals administered with naltrexone, subsequent opiate injections will have reduced or no effect, therefore aiding in the treatment of narcotic dependence. Engaging in a narcotic treatment program with naltrexone can be beneficial for those who have much to gain from being drug-free.
It is also important to note that other substances like Methylenedioxypyrovalerone (MDPV) and mephedrone are psychoactive drugs with stimulant properties that have been sold as designer drugs, although they bear no direct relation to methylNaltrexone or naltrexone in their uses or chemical properties.